Skin diseases are common in all ages and in all countries and cultures, and the number of skin patients accounts for 30% to 70% of the world's population. Therefore, the global market for dermatological drugs is huge. CD BioSciences has extensive expertise in a variety of common skin disorders including acne, dermatitis, atopic eczema, acne vulgaris, psoriasis and other indications. If you want to enter this dermatological market and need to analyze the safety and effectiveness of your drugs in clinical trials, then we will be your best resource. Our dermatologists will guide you from preclinical, proof-of-concept to clincal to help you bring new therapies to market with success.